| 11/16/2026 9:00 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 8:03 AM | Avoro Capital Advisors LLC (1633313) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 7:48 AM | Deep Track Capital, LP (1856083) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 11/10/2026 8:34 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G | |
| 11/05/2026 3:10 PM | Vera Therapeutics (1831828) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/17/2026 3:28 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 5:45 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/04/2026 3:15 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 11:16 AM | Kynam Capital Management, LP (1907884) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 08/12/2026 5:39 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4/A | |
| 08/12/2026 5:41 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4/A | |
Get the Latest News and Ratings for VERA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/12/2026 5:42 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4/A | |
| 08/10/2026 3:05 PM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2026 10:09 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G | |
| 07/30/2026 10:18 AM | BlackRock, Inc. (2012383) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 07/09/2026 3:45 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 7:00 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/07/2026 11:45 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2026 3:55 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 3:29 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 6:05 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/26/2026 3:54 PM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/26/2026 3:17 PM | MORRISSEY MICHAEL (1202096) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:18 PM | Hall Kimball (1897965) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:19 PM | Meyers James R (1387521) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:20 PM | Oliger Christy J. (1822092) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:22 PM | SEIDENBERG BETH C (1184592) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 9:07 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 05/12/2026 3:33 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/07/2026 3:33 PM | Vera Therapeutics (1831828) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 6:30 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 3:57 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/14/2026 3:33 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/09/2026 3:05 PM | Vera Therapeutics (1831828) Filer | Form DEF 14A | |
| 04/09/2026 3:05 PM | Vera Therapeutics (1831828) Filer | Form DEFA14A | |
| 04/09/2026 3:06 PM | Vera Therapeutics (1831828) Filer | Form ARS | |
| 04/01/2026 4:32 PM | Point72 Asset Management, L.P. (1603466) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G | |
| 03/27/2026 12:50 PM | VANGUARD GROUP INC (102909) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 03/25/2026 6:06 PM | Vera Therapeutics (1831828) Issuer Wright-Mitchell Jane (1614568) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/25/2026 6:08 PM | Vera Therapeutics (1831828) Issuer Wright-Mitchell Jane (1614568) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 5:52 PM | Vera Therapeutics (1831828) Issuer Young Joseph R (1861684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
My public warning after 55 years of watching the markets (Ad) Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.
Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks. See Martin Weiss's full warning before this risk spreads further |
| 03/05/2026 5:11 AM | Sofinnova Venture Partners X, L.P. (1680200) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13D/A | |
| 02/26/2026 4:25 PM | Vera Therapeutics (1831828) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 6:30 AM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 6:53 PM | Skelton Laurence Matthew (2108080) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:56 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:57 PM | JOHNSON DAVID LEE (1733883) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:58 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:59 PM | Grant Sean (1872792) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 7:00 PM | Vera Therapeutics (1831828) Issuer Young Joseph R (1861684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 7:01 PM | Brenner Robert (2006910) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:39 PM | Brenner Robert (2006910) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:41 PM | Grant Sean (1872792) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:42 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:44 PM | Skelton Laurence Matthew (2108080) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:31 PM | JOHNSON DAVID LEE (1733883) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 9:26 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 02/06/2026 7:00 PM | Brenner Robert (2006910) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | JOHNSON DAVID LEE (1733883) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | Skelton Laurence Matthew (2108080) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | Grant Sean (1872792) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | Fordyce Marshall (1859453) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 7:00 PM | Vera Therapeutics (1831828) Issuer Young Joseph R (1861684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 12:40 PM | FMR LLC (315066) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G/A | |
| 01/30/2026 1:43 PM | VANGUARD GROUP INC (102909) Filed by Vera Therapeutics (1831828) Subject | Form SCHEDULE 13G | |
| 12/17/2025 3:05 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 7:07 PM | ENRIGHT PATRICK G (1253886) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:17 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/10/2025 4:18 PM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 3:21 PM | Vera Therapeutics (1831828) Filer | Form 424B5 | |
| 12/08/2025 3:41 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/08/2025 3:07 PM | Vera Therapeutics (1831828) Filer | Form 424B5 | |
| 12/04/2025 3:05 PM | Turner William D. (1819688) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:30 PM | Vera Therapeutics (1831828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 3:35 PM | Meyers James R (1387521) Reporting Vera Therapeutics (1831828) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/26/2025 3:37 PM | Meyers James R (1387521) Reporting Vera Therapeutics (1831828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 8:22 PM | Carter Jason S (2045094) Reporting Vera Therapeutics (1831828) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |